Ema, an AI platform focused on women’s health, announced it has raised more than $3 million in funding after closing its latest investment round .
The platform is trained on a proprietary dataset of 10 million interactions between women and physicians discussing health and wellness.
Ema uses this data to provide features such as administering clinically validated assessments, aiming to improve health outcomes from a woman’s first period through post-menopause.
Emmeline Ventures, a firm focused on supporting female-led companies, led the round, with participation from previous investors Kubera Venture Capital and Victorum Capital . .
Emmeline Ventures’ managing partner, La Keisha Landrum Pierre, said the firm invested in Ema due to its potential to redefine women’s health via a combination of empathy and cutting-edge technology .
Pierre noted that Ema goes beyond just generative AI to offering a trusted partner who knows more about women’s unique needs and empowering them and their families to access quality care seamlessly.
In its first six months, Ema generated over $1 million in contract value. The funding will support continued AI innovation and its enterprise clients, including PatientsLikeMe and Willow.
Amanda Ducach, CEO of Ema, cited an example of the platform’s impact on perinatal mental health. She said 75% of women who took the Edinburgh Postnatal Depression Scale (EPDS) assessment through Ema subsequently sought professional mental health support. Additionally, 34% of women engaging with Ema during a campaign showed signs of depression.
Ducach emphasized the Ema platform’s ability to foster meaningful engagement and also connect women to care, delivering a transformative impact in addressing common mental health challenges at large.
Ema said it is positioned for continued growth, serving women’s health organizations and providing solutions for women.
